Elsevier to Create eLearning Programs for PAH and Other Respiratory Specialists

Patrícia Silva, PhD avatar

by Patrícia Silva, PhD |

Share this article:

Share article via email
eLearning and CHEST

Elsevier  announced that it is expanding its work with the American College of Chest Physicians (CHEST) to provide CHEST members with detailed and interactive eLearning programs that address their specialities, including pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD).

Elsevier is a provider of scientific, technical and medical information products, and the publisher of the journal CHEST – the organization’s official publication.

The Elsevier eLearning solutions will offer CHEST members content that is both evidence-based and peer-reviewed. The effort will focus on specific diseases, like COPD and PAH, along with related risk factors, treatment, complications, and patient education. The program will include case studies, videos, animation and other interactive elements.

CHEST specialties that will be able to use the new service include pulmonary, critical care, and sleep medicine.

In an article titled “The Effectiveness of E-Learning: An Explorative and Integrative Review of the Definitions, Methodologies and Factors that Promote e-Learning Effectiveness,” published in 2015, a group of researchers from Denmark praised online training as a cost-effective, convenient, and effective way to deliver education, although recommending further research.

“The powerful combination of CHEST’s expertise, as reflected in its membership, and Elsevier’s position as the leading provider of healthcare eLearning, ensures that clinicians from various disciplines will have access to valuable continuing education opportunities,” Barbara Nelson Cullen, vice-president of strategy and content development at Elsevier, said in a press release.

CHEST works to advance best patient outcomes through innovative chest medicine education, clinical research and team-based care. Its mission is to be a leader in the prevention, diagnosis and treatment of chest conditions, including pulmonary diseases, through education, communication, and research. CHEST has 19,000 members worldwide.

Elsevier develops solutions to educate and empower research professionals. It owns scientific databases like ScienceDirectScopusResearch Intelligence and ClinicalKey, and publishes more than 2,500 journals, including The Lancet and Cell. Elsevier has also published over 35,000 books, some of which are now considered leaders in their fields of reference.